Treatments & Interventions
Thalidomide
substance
Interferon alfacon-1
substance
Medroxyprogesterone acetate
substance
Medroxyprogesterone
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Aldesleukin
substance
Hydroxyurea
substance
Peginterferon alfa-2b
substance
Sunitinib
substance
Peginterferon alfa-2a
substance
Sorafenib
substance
Sunitinib malate
substance
Temsirolimus
substance
Axitinib
substance
Sorafenib tosylate
substance
Pazopanib
substance
Lenvatinib
substance
Cabozantinib
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 702391001
- UMLS CUI
- C0007134
- Fully Specified Name
- Renal cell carcinoma (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 1
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.